ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve [Yahoo! Finance]
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: Yahoo! Finance
Shares of ImmuCell Corporation ICCC have declined 0.8% since reporting results for the fourth quarter of 2025. This compares with the S&P 500 index's 0.7% return over the same time frame. Over the past month, the stock has lost 4.3% compared with the S&P 500's 1.7% fall. For the year ended Dec. 31, 2025, ImmuCell reported product sales of $27.6 million, a 4.3% increase from $26.5 million in 2024. The company's profitability metrics improved significantly year over year. Net loss narrowed to $1 million, or 12 cents per basic share, from a net loss of $2.2 million, or 26 cents per basic share, in the prior year. The gross margin expanded sharply to 41.4% of product sales in 2025 from 30% in 2024, reflecting operational improvements and stronger sales volumes. ImmuCell Corporation Price, Consensus and EPS Surprise ImmuCell Corporation Price, Consensus and EPS Surprise ImmuCell Corporation price-consensus-eps-surprise-chart | ImmuCell Corporation Quote Other Key Business Metric
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025GlobeNewswire
- ImmuCell (ICCC) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d+)" to "hold (c-)".MarketBeat
- ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 [Yahoo! Finance]Yahoo! Finance
ICCC
Sec Filings
- 3/4/26 - Form 8-K
- 2/9/26 - Form 8-K
- 2/2/26 - Form 8-K
- ICCC's page on the SEC website